keyword
https://read.qxmd.com/read/38098569/mechanical-thrombectomy-for-ais-from-large-vessel-occlusion-current-trends-and-future-perspectives
#1
REVIEW
Gauri Parvathy, Rohit C Dey, Lakshmi Venkata Simhachalam Kutikuppala, Aakansh R Maheshwari, Elwy Josey, Jyothi S Chintala, Mohammed Abdullah, Swathi Godugu
Stroke is found to be one of the global top causes of mortality and the major factor in years of life with a handicap (DALYs). Ischemic strokes contributed to nearly 70% of all strokes worldwide. For endovascular thrombectomy in acute ischemic stroke with large vessel obstruction (AIS-LVO), using stent retrievers and/or reperfusion catheters has become the gold standard of therapy. The methodology involved keyword-based search in databases like PubMed, Embase, and Google Scholar for recent publications on mechanical thrombectomy (MT), AIS, large vessel occlusion (Large Vessel Occlusion (LVO)), screening relevant articles, retrieving full texts, and synthesizing key findings on procedural advancements, patient selection, COVID-19 (coronavirus disease 2019) impact, delay effects, effectiveness, clinical outcomes, and future perspectives...
December 2023: Annals of Medicine and Surgery
https://read.qxmd.com/read/37810545/homocysteine-reduction-for-stroke-prevention-regarding-the-recent-aha-asa-2021-prevention-of-stroke-in-patients-with-stroke-and-transient-ischemic-attack
#2
JOURNAL ARTICLE
Craig Brown, Jianhua Wang, Hong Jiang, Merrill F Elias
Reduction of secondary ischemic stroke risk following an initial stroke is an important goal. The 2021 Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack assembles opportunities for up to 80% secondary stroke reduction. Homocysteine reduction was not included in the recommendations. The reduction of homocysteine with low doses of folic acid has been shown to reduce ischemic stroke and all stroke. This has been obscured by studies using high doses of folic acid and cyanocobalamin in patients with renal failure and Methylenetetrahydrofolate reductase (MTHFR) polymorphisms...
2023: Pharmacogenomics and Personalized Medicine
https://read.qxmd.com/read/37559709/evaluation-of-physicians-compliance-with-secondary-prevention-among-ischemic-stroke-patients-a-retrospective-study
#3
JOURNAL ARTICLE
Alaa Alhubaishi, Maha A Almutairi, Malak A Alasqah, Shihanah H Alharthi, Abdulhadi M Alqahtani, Lina I Alnajjar
BACKGROUND: Stroke is a leading cause of disability and death worldwide. Globally, stroke affects 13.7 million individuals every year. Several studies have shown an increase in the rehospitalization rate among stroke patients caused by non-adherence to secondary prevention as recommended by the American Heart Association/American Stroke Association (AHA/ASA) guideline. The aim of this study was to evaluate physicians' compliance with secondary prevention of stroke upon patients' discharge...
August 2023: Cardiology Research
https://read.qxmd.com/read/37441200/improving-access-to-specialist-palliative-care-for-patients-with-catastrophic-strokes-using-best-practice-advisory-a-feasibility-study
#4
JOURNAL ARTICLE
Vandana Nagpal, Marcey L Osgood, Jennifer Reidy, Rose Healy, Brian Silver
BACKGROUND AND PURPOSE: The American Heart Association and American Stroke Association (AHA/ASA) strongly recommend specialty palliative care (PC) for all patients hospitalized with life-threatening or life-altering strokes to provide expert symptom management, improve communication, promote shared decision-making and relieve suffering. We piloted an intervention to remind physicians about high PC needs of their patients admitted with catastrophic stroke. METHODS: We worked with colleagues from medical informatics to create a "Best Practice Advisory" (BPA) to recommend a goals-of-care conversation and PC consultation for patients with a National Institutes of Health Stroke Scale (NIHSS) score of 20 or more in our electronic medical record (Epic)...
July 2023: Neurohospitalist
https://read.qxmd.com/read/37419695/decoding-the-data-a-comment-on-the-american-heart-association-american-stroke-association-aha-asa-2023-guideline-for-the-management-of-patients-with-aneurysmal-subarachnoid-hemorrhage
#5
JOURNAL ARTICLE
Justin F Fraser, Jeremy J Heit, Justin R Mascitelli, Jenny P Tsai
No abstract text is available yet for this article.
September 2023: Journal of Neurointerventional Surgery
https://read.qxmd.com/read/37360512/the-positive-predictive-value-of-pediatric-stroke-diagnoses-in-administrative-data-a-retrospective-validation-study
#6
JOURNAL ARTICLE
Julie Brix Bindslev, Soeren Paaske Johnsen, Klaus Hansen, Jan Brink Valentin, Christina Engel Hoei-Hansen, Thomas Truelsen
BACKGROUND: This retrospective cohort study aimed to examine the positive predictive value (PPV) of pediatric stroke diagnoses in the Danish National Registry of Patients (DNRP) and the impact of different stroke definitions on the PPV. METHODS: We included children registered with a stroke or stroke-related diagnosis in the DNRP between January 2017 through December 2020. Two assessors reviewed medical records and validated cases according to the American Heart and American Stroke Association (AHA/ASA) stroke definition...
2023: Clinical Epidemiology
https://read.qxmd.com/read/37126821/prioritizing-quality-measures-in-acute-stroke-care-a-cost-effectiveness-analysis
#7
Jinyi Zhu, Hooman Kamel, Ajay Gupta, Alvin I Mushlin, Nicolas A Menzies, Thomas A Gaziano, Meredith B Rosenthal, Ankur Pandya
BACKGROUND: The American Heart Association and American Stroke Association (AHA/ASA) endorsed 15 process measures for acute ischemic stroke (AIS) to improve the quality of care. Identifying the highest-value measures could reduce the administrative burden of quality measure adoption while retaining much of the value of quality improvement. OBJECTIVE: To prioritize AHA/ASA-endorsed quality measures for AIS on the basis of health impact and cost-effectiveness. DESIGN: Individual-based stroke simulation model...
May 2023: Annals of Internal Medicine
https://read.qxmd.com/read/36934518/prevalence-and-prognosis-of-seizures-among-patients-undergoing-mechanical-thrombectomy-for-acute-ischemic-stroke-a-look-at-pre-2015-aha-asa-guidelines-update-regarding-endovascular-treatment
#8
JOURNAL ARTICLE
Alain Lekoubou, Yael Pinero Colon, Kinfe G Bishu, Ajah T Ngonde, Leonardo Bonilha, Bruce Ovbiagele
BACKGROUND: Mechanical Thrombectomy (MT) is standard of care for eligible patients with Acute Ischemic Stroke (AIS) due to large vessel occlusion (LVO). With increasing use of MT, clinicians are more likely to encounter seizures, a potential complication of AIS treated with MT. Tracking future trends in the burden of post-stroke seizure associated with MT will require baseline pre-approval benchmark estimates of its frequency and outcomes. METHODS: All patients with AIS who underwent MT (International Classification of Diseases, Ninth Revision, Clinical Modification; ICD-9-CM procedure code: 39...
March 17, 2023: Journal of Stroke and Cerebrovascular Diseases: the Official Journal of National Stroke Association
https://read.qxmd.com/read/36365181/development-and-evaluation-of-a-physiologically-based-pharmacokinetic-model-of-labetalol-in-healthy-and-diseased-populations
#9
JOURNAL ARTICLE
Hafsa Hafsa, Ammara Zamir, Muhammad Fawad Rasool, Imran Imran, Hamid Saeed, Tanveer Ahmad, Sary Alsanea, Ali A Alshamrani, Abdullah H Alruwaili, Faleh Alqahtani
Labetalol is a drug that exhibits both alpha and beta-adrenergic receptor-blocking properties. The American Heart Association/American Stroke Association (AHA/ASA) has recommended labetalol as an initial treatment option for the management of severe hypertension. The physiologically based pharmacokinetic (PBPK) model is an in silico approach to determining the pharmacokinetics (PK) of a drug by incorporating blood flow and tissue composition of the organs. This study was conducted to evaluate the primary reasons for the difference in PK after intravenous (IV) and oral administration in healthy and diseased (renal and hepatic) populations...
November 2, 2022: Pharmaceutics
https://read.qxmd.com/read/35980797/a-nursing-approach-to-improving-critical-care-compliance-with-vital-signs-and-neurological-assessments-in-post-iv-alteplase-stroke-patients
#10
JOURNAL ARTICLE
Vicki L Cohen, Amanda Anderson, Patty Noah, Jamie Super
Ischemic stroke represents 87% of all strokes. As global initiatives move forward with stroke care, health care providers and institutions will be called on to deliver the most current evidence-based care. The American Heart Association/American Stroke Association (AHA/ASA) estimates that 795 000 strokes occur each year; 610 000 are new strokes, and 185 000 are recurrent strokes. Eighty-seven percent are ischemic strokes; the overall mortality rate from stroke was 273 000, which makes stroke the fifth leading cause of death and the leading cause of disability in the United States...
October 2022: Critical Care Nursing Quarterly
https://read.qxmd.com/read/35976291/updates-on-aneurysmal-subarachnoid-hemorrhage-is-there-anything-really-new
#11
REVIEW
Thire Baggio Machado Marazzi, Pedro Vitale Mendes
Aneurysmal subarachnoid hemorrhage (aSAH) is a severe disease, with systemic involvement and complex diagnosis and treatment. Since the current guidelines were published by the AHA/ASA, Neurocritical Care Society and the European Stroke Organization in 2012-2013,there has been an evolution in the comprehension of SAH-associated brain injury and its multiple underlying mechanisms. As a result, several clinical and translational trials were developed or are underway. Objective: The aim of this article is to review some updates in the diagnosis and treatment of neurological complications of SAH...
May 2022: Arquivos de Neuro-psiquiatria
https://read.qxmd.com/read/35900761/analysis-of-prescriptions-for-dual-antiplatelet-therapy-after-acute-ischemic-stroke
#12
MULTICENTER STUDY
Ying Xian, Haolin Xu, Roland Matsouaka, Daniel T Laskowitz, Lesley Maisch, Deidre Hannah, Eric E Smith, Gregg C Fonarow, Deepak L Bhatt, Lee H Schwamm, Brian Mac Grory, Wuwei Feng, Emil Loldrup Fosbøl, Eric D Peterson, Mark Johnson
Importance: After the publication of the CHANCE (Clopidogrel in High Risk Patients With Acute Nondisabling Cerebrovascular Events) and POINT (Platelet-Oriented Inhibition in New Transient Ischemic Attack and Minor Ischemic Stroke) clinical trials, the American Heart Association/American Stroke Association (AHA/ASA) issued a new class 1, level of evidence A, recommendation for dual antiplatelet therapy (DAPT; aspirin plus clopidogrel) for secondary prevention in patients with minor ischemic stroke (National Institutes of Health Stroke Scale [NIHSS] score ≤3)...
July 1, 2022: JAMA Network Open
https://read.qxmd.com/read/35812086/different-doses-of-intravenous-tissue-type-plasminogen-activator-for-acute-ischemic-stroke-a-network-meta-analysis
#13
Bing-Hu Li, Jian-Hong Wang, Han Wang, Duo-Zi Wang, Shu Yang, Fu-Qiang Guo, Neng-Wei Yu
Background: This study aims to assess the efficacy and safety of different doses of intravenous tissue-type plasminogen activator (tPA) for acute ischemic stroke (AIS) by adopting a network meta-analysis (NMA). Methods: Studies comparing different doses of tPA in AIS were identified by retrieving electronic databases. NMAs of outcome measures included favorable functional outcome with a modified Rankin scale score (mRS) of 0 or 1 at 3 months after treatment (3M-FF), the functional independence with a mRS of 0, 1, or 2 at 3 months (3M-FI), symptomatic intracranial hemorrhage (sICH) and 3-month all-cause mortality (3M-M)...
2022: Frontiers in Neurology
https://read.qxmd.com/read/35543860/diagnosis-and-management-of-stroke-in-adults-with-primary-brain-tumor
#14
REVIEW
Edina Komlodi-Pasztor, Mark R Gilbert, Terri S Armstrong
PURPOSE OF REVIEW: This article reviews the risk factors, clinical presentations, differential diagnosis, and the types of strokes frequently seen in patients with primary brain neoplasms. This includes a discussion of approaches with a review of the available literature and provides recommendations for primary and secondary prevention specific to this patient population. RECENT FINDINGS: Strokes in patients with brain tumors are often multifactorial. However, tailored approaches to stroke care are necessary to achieve optimal patient outcomes, AHA/ASA stroke guidelines provide little information on the management of stroke in cancer patients...
May 11, 2022: Current Oncology Reports
https://read.qxmd.com/read/35029929/secondary-prevention-of-ischemic-stroke-updated-guidelines-from-aha-asa
#15
COMMENT
Brian Ford, Suman Peela, Caroline Roberts
No abstract text is available yet for this article.
January 1, 2022: American Family Physician
https://read.qxmd.com/read/35006660/stroke-primary-prevention
#16
JOURNAL ARTICLE
Waimei Amy Tai
Stroke is a leading cause of long-term disability in adults and the fifth leading cause of mortality in the United States. One of the main tasks related to stroke in the family medicine setting is assessment and management of modifiable risk factors. The American Heart Association/American Stroke Association (AHA/ASA) guidelines on primary prevention of stroke recommend that cigarette smoking, physical inactivity, overweight and obesity, dyslipidemia, hypertension, and diabetes be addressed and/or managed to decrease the risk of stroke...
January 2022: FP Essentials
https://read.qxmd.com/read/34880092/ischemic-stroke-and-pulmonary-arteriovenous-malformations-a-review
#17
REVIEW
Karan K Topiwala, Smit D Patel, Jeffrey L Saver, Christopher D Streib, Claire L Shovlin
The potential of covert pulmonary arteriovenous malformations (PAVMs) to cause early onset, preventable ischemic strokes is not well known to neurologists. This is evident by their lack of mention in serial American Heart Association/American Stroke Association (AHA/ASA) Guidelines and the single case report biased literature of recent years. We performed PubMed and Cochrane database searches for major studies on ischemic stroke and PAVMs published from January 1, 1974, through April 3, 2021. This identified 24 major observational studies, 3 societal guidelines, 1 nationwide analysis, 3 systematic reviews, 21 other review/opinion articles, and 18 recent (2017-2021) case reports/series that were synthesized...
February 1, 2022: Neurology
https://read.qxmd.com/read/34879377/two-sides-of-a-coin-case-report-of-unilateral-synangiosis-and-contralateral-stroke-highlighting-consequences-of-disease-progression-and-efficacy-of-revascularization-in-sickle-cell-disease-associated-moyamoya-syndrome
#18
Anna L Slingerland, Madeline B Karsten, Edward R Smith, Amy E Sobota, Alfred P See
Moyamoya syndrome increases the risk of stroke in sickle cell disease, but revascularization surgery can modify this risk. Collaborative management between hematology and neurosurgery offers effective strategies to reduce stroke risk in these patients. We describe a challenging case where a patient with sickle cell disease undergoing standard of care management as prescribed by the Stroke Prevention Trial in Sickle Cell Anemia (STOP) and revascularization with pial synangiosis subsequently developed rapidly progressive disease in other cerebral vessels and suffered ischemic hemispheric stroke...
December 8, 2021: Acta Haematologica
https://read.qxmd.com/read/34584802/anticoagulation-after-ischemic-stroke-or-transient-ischemic-attack-tia-in-the-time-of-direct-oral-anticoagulation-doac-and-thrombectomy
#19
JOURNAL ARTICLE
Claudia Martin Diaz, Eduardo A Guizan Corrales, Starlie C Belnap, Jonathan Kline, Radhan Gopalani, Sylvia Marrero, Felipe De Los Rios La Rosa
Objective To assess anticoagulation (AC) timing and appropriateness in patients with acute ischemic stroke (AIS) or transient ischemic attack (TIA) due to atrial fibrillation (AF) in a predominantly Hispanic community hospital in the era of direct oral AC (DOAC) and endovascular thrombectomy (EVT). Methods Adult patients presenting with known or new-onset AF and primary diagnosis of AIS/TIA admitted to Baptist Hospital of Miami between January 2018 and January 2019 were included. AC appropriateness was determined on medical history and concordance with American Heart Association AHA/American Stroke Association (ASA) AC guidelines...
August 2021: Curēus
https://read.qxmd.com/read/34495437/patterns-of-prophylactic-anticonvulsant-use-in-spontaneous-intracerebral-and-subarachnoid-hemorrhage-results-of-a-practitioner-survey
#20
JOURNAL ARTICLE
Michael J Gigliotti, Shwetha Srikanth, Kevin M Cockroft
BACKGROUND: The use of prophylactic anti-seizure medications (ASMs) in the management of patients with spontaneous intracerebral hemorrhage (sICH) and aneurysmal subarachnoid hemorrhage (aSAH) is controversial. OBJECTIVE: The purpose of this survey was to better characterize the current state of prophylactic ASM use in sICH and aSAH in North America. METHODS: US and Canadian neurosurgeons, neurologists, and interventional neuroradiologists with an interest in or expertise in the management of neurovascular disease were surveyed using an electronic survey tool...
March 2022: Neurological Sciences
keyword
keyword
111227
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.